The protective effect of Egb 761 against 3-Nitropropionic acid-induced hearing loss: the role of Sirtuin 1
For patients suffering from metabolic disorders, where the use of L-Carnitine is impaired or the requirements are increased, an L-Carnitine 50 mg/ml Oral Liquid formulation provides essential support
Improved Metabolic Markers Both compounds independently improve metabolic health indicators
To Ciprofloxacin 0.3% W/v & Dexamethasone 0.1% W/v AGROSIP EYE / EAR DROP - CIPROFLOXACIN (0.3% W/V) AROLUB DS EYE DROP - Carboxymethylcellulose (1% w/v AROLUB EYE DROP - Carboxymethylcellulose (0.5% w/v) ATROCINE EYE DROP - Atropin Sulphate Ip (0.01% W/v) + Stabilized Oxychloo Complex (0.005% W/v) BIMROST EYE DROP - BIMATOPROST 0.03% w/v, STERILE AQUEOUS BASE
BPC-157, Body Protection Compound-157, , (BPC),
Sleeping well and managing stress